Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 3706 AL 3720

Precision machine learning to understand micro-RNA regulation in neurodegenerative diseases

Mégret L, Mendoza C, Arrieta Lobo M, Brouillet E, Nguyen TT, Bouaziz O, Chambaz A, Néri C.

Front Mol Neurosci. 2022 Sep 9;15:914830. doi: 10.3389/fnmol.2022.914830. eCollection 2022.

The role of brain derived neurotrophic factor in central nervous system

Li Y, Li F, Qin D, Chen H, Wang J, Wang J, Song S, Wang C, Wang Y, Liu S, Gao D, Wang ZH.

Front Aging Neurosci. 2022 Sep 8;14:986443. doi: 10.3389/fnagi.2022.986443. eCollection 2022.

Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta-Analysis

Medina A, Mahjoub Y, Shaver L, Pringsheim T.

Mov Disord. 2022 Dec;37(12):2327-2335. doi: 10.1002/mds.29228. Epub 2022 Sep 26.

[Transcription Factor Sp1 in the Expression of Genes Encoding Components of MAPK, JAK/STAT, and PI3K/Akt Signaling Pathways]

Ivanenko KA, Prassolov VS, Khabusheva ER.

Mol Biol (Mosk). 2022 Sep-Oct;56(5):832-847. doi: 10.31857/S0026898422050081.

Group A Beta-Hemolytic Streptococcus-Induced Tic-Like Movement Disorder in an Adult: A Case Report

Ilyas U, Umar Z, Lin D.

Cureus. 2022 Aug 26;14(8):e28451. doi: 10.7759/cureus.28451. eCollection 2022 Aug.

Huntington's Disease: A Clinical Review

Andhale R, Shrivastava D.

Cureus. 2022 Aug 27;14(8):e28484. doi: 10.7759/cureus.28484. eCollection 2022 Aug.

Molecular Mechanisms of the Neuroprotective Effect of Methylene Blue

Gureev AP, Sadovnikova IS, Popov VN.

Biochemistry (Mosc). 2022 Sep;87(9):940-956. doi: 10.1134/S0006297922090073.

Manganese and related neurotoxic pathways: A potential therapeutic target in neurodegenerative diseases

Chib S, Singh S.

Neurotoxicol Teratol. 2022 Nov-Dec;94:107124. doi: 10.1016/j.ntt.2022.107124. Epub 2022 Sep 30.

The emerging role of long non-coding RNAs, microRNAs, and an accelerated epigenetic age in Huntington's disease

Ghafouri-Fard S, Khoshbakht T, Hussen BM, Taheri M, Ebrahimzadeh K, Noroozi R.

Front Aging Neurosci. 2022 Sep 15;14:987174. doi: 10.3389/fnagi.2022.987174. eCollection 2022.

Oxytocin in Huntington's disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia

Bergh S, Cheong RY, Petersén Å, Gabery S.

Front Mol Neurosci. 2022 Sep 14;15:984317. doi: 10.3389/fnmol.2022.984317. eCollection 2022.

Aging RNA granule dynamics in neurodegeneration

Rhine K, Al-Azzam N, Yu T, Yeo GW.

Front Mol Biosci. 2022 Sep 16;9:991641. doi: 10.3389/fmolb.2022.991641. eCollection 2022.

Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction

Yadav E, Yadav P, Khan MMU, Singh H, Verma A.

Front Pharmacol. 2022 Sep 16;13:922232. doi: 10.3389/fphar.2022.922232. eCollection 2022.

Use of Objective Outcomes Measures to Verify the Effects of ICF-Based Gait Treatment in Huntington's Disease Patient on Globus Pallidus Deep Brain Stimulation: A Case Report

Capato TTC, Cury RG, Tornai J, Fonoff ET, Guimarães R, Jacobsen MT, Haddad MS, Barbosa ER.

Front Rehabil Sci. 2022 Apr 14;3:849333. doi: 10.3389/fresc.2022.849333. eCollection 2022.

[Hemidystonia and hemichorea in a pediatric patient with glucose transporter type 1 deficiency]

Menalled GS, Montero S, Faustinelli V, Poeta Casalis LDV, Crespo D, Colombo H.

Arch Argent Pediatr. 2022 Oct;120(5):e207-e209. doi: 10.5546/aap.2022.e207. Epub 2022 Aug 30.

Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington's disease

Saha S, Dey MJ, Promon SK, Araf Y.

Regen Ther. 2022 Sep 25;21:406-412. doi: 10.1016/j.reth.2022.09.001. eCollection 2022 Dec.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias